Sort by
Refine Your Search
-
that combine high efficacy with reduced adverse effects and the ability to overcome mechanisms of treatment resistance. The project aims to identify unique combinations of chemotherapeutic agents and hormone
-
Technologies of the University of Warsaw. Field: Chemical sciences Project title: Development of new antibacterial agents based on lytic enzymes produced by bacteriophages Project leader: Monika Wojciechowska
-
a research group redefining how drugs shape cellular fate under stress. We are building a next-generation platform to discover and develop several novel classes of transition-modulating agents
-
anticancer agents, including cisplatin and the antileukemic nucleoside analogues fludarabine and cladribine, were strongly influenced by p53 status. These findings suggest that these novel compounds may
-
. Susceptibility of selected complex/micelle systems to reducing agents. Cu(II) complexes must be reduced to Cu(I) for hCtr1 transport. This will be tested using GSH, cysteine and ascorbate. The interference by